Compare KTOS & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KTOS | ALGN |
|---|---|---|
| Founded | 1994 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.4B | 12.0B |
| IPO Year | 1999 | N/A |
| Metric | KTOS | ALGN |
|---|---|---|
| Price | $84.81 | $175.53 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 11 |
| Target Price | $97.00 | ★ $186.40 |
| AVG Volume (30 Days) | ★ 4.5M | 1.0M |
| Earning Date | 02-25-2026 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 27.23 | 0.53 |
| EPS | 0.13 | ★ 5.65 |
| Revenue | $1,284,800,000.00 | ★ $4,034,964,000.00 |
| Revenue This Year | $19.25 | $5.33 |
| Revenue Next Year | $20.52 | $4.61 |
| P/E Ratio | $674.44 | ★ $31.08 |
| Revenue Growth | ★ 14.00 | 0.90 |
| 52 Week Low | $23.90 | $122.00 |
| 52 Week High | $134.00 | $232.20 |
| Indicator | KTOS | ALGN |
|---|---|---|
| Relative Strength Index (RSI) | 41.56 | 64.73 |
| Support Level | $84.50 | $154.83 |
| Resistance Level | $103.49 | $179.91 |
| Average True Range (ATR) | 8.33 | 5.34 |
| MACD | -4.52 | 0.22 |
| Stochastic Oscillator | 10.04 | 89.79 |
Kratos Defense & Security Solutions Inc develops and fields transformative, affordable technology, platforms, and systems. The company has two segments; The Kratos Government Solutions (KGS) segment is comprised of an aggregation of KGS operating segments, including its microwave electronic products, space, training, and cybersecurity, C5ISR/modular systems, turbine technologies, and defense and rocket support services operating segments and The Unmanned Systems segment consists of unmanned aerial, unmanned ground, unmanned seaborne and related command, control, and communications system businesses. The company derives a majority of its revenue from the Kratos Government Solutions segment.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.